Cargando…

Hidden GBV: Women and substance use

Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARA...

Descripción completa

Detalles Bibliográficos
Autores principales: Moir, Eilidh, Gwyther, Sophie, Wilkins, Heather, Boland, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393579/
https://www.ncbi.nlm.nih.gov/pubmed/36003973
http://dx.doi.org/10.3389/fpsyt.2022.939105
_version_ 1784771300710940672
author Moir, Eilidh
Gwyther, Sophie
Wilkins, Heather
Boland, Gillian
author_facet Moir, Eilidh
Gwyther, Sophie
Wilkins, Heather
Boland, Gillian
author_sort Moir, Eilidh
collection PubMed
description Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARAC) in Dundee. The majority of these cases (62) had substance misuse as a risk factor. It is at these meetings that the vulnerability of women comes to the fore and issues of violence are highlighted. During this time period, 44 cases involved the victim being strangled/choked or suffocated and 43 cases had weapons as a risk factor. 56 of the cases included children. The issue of GBV or Intimate Partner Violence (IPV) is often hidden, especially in and by those affected by substance use. Women experiencing GBV require specialist support, often across different services to address different needs. How well violence against women is understood in relationships that are affected by drugs is difficult to determine. In many instances it isn't until a MARAC meeting, or similar crisis point is met, that the extent of the abuse is highlighted. What services can provide singularly is limited in many of these cases but joint-working and innovative practices, such as the Hub model and the Gendered Services Project in Dundee, strive to change the landscape of service delivery.
format Online
Article
Text
id pubmed-9393579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93935792022-08-23 Hidden GBV: Women and substance use Moir, Eilidh Gwyther, Sophie Wilkins, Heather Boland, Gillian Front Psychiatry Psychiatry Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARAC) in Dundee. The majority of these cases (62) had substance misuse as a risk factor. It is at these meetings that the vulnerability of women comes to the fore and issues of violence are highlighted. During this time period, 44 cases involved the victim being strangled/choked or suffocated and 43 cases had weapons as a risk factor. 56 of the cases included children. The issue of GBV or Intimate Partner Violence (IPV) is often hidden, especially in and by those affected by substance use. Women experiencing GBV require specialist support, often across different services to address different needs. How well violence against women is understood in relationships that are affected by drugs is difficult to determine. In many instances it isn't until a MARAC meeting, or similar crisis point is met, that the extent of the abuse is highlighted. What services can provide singularly is limited in many of these cases but joint-working and innovative practices, such as the Hub model and the Gendered Services Project in Dundee, strive to change the landscape of service delivery. Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393579/ /pubmed/36003973 http://dx.doi.org/10.3389/fpsyt.2022.939105 Text en Copyright © 2022 Moir, Gwyther, Wilkins and Boland. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Moir, Eilidh
Gwyther, Sophie
Wilkins, Heather
Boland, Gillian
Hidden GBV: Women and substance use
title Hidden GBV: Women and substance use
title_full Hidden GBV: Women and substance use
title_fullStr Hidden GBV: Women and substance use
title_full_unstemmed Hidden GBV: Women and substance use
title_short Hidden GBV: Women and substance use
title_sort hidden gbv: women and substance use
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393579/
https://www.ncbi.nlm.nih.gov/pubmed/36003973
http://dx.doi.org/10.3389/fpsyt.2022.939105
work_keys_str_mv AT moireilidh hiddengbvwomenandsubstanceuse
AT gwythersophie hiddengbvwomenandsubstanceuse
AT wilkinsheather hiddengbvwomenandsubstanceuse
AT bolandgillian hiddengbvwomenandsubstanceuse